InsidersTradesSigma
Total declarations
Company
▲ Purchases (1 ops.)
▼ Sales (0 ops.)
Insider track record
ExecutiveDisclosed buys
1
Disclosed sells
0
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
Signal history
Discover the full record of transactions filed by Remmel H. Lawrence, Director. Director active across 1 company, notably Atossa Therapeutics, INC.. Cumulatively, 3 filings have been logged. Split: 1 buy · 0 sell. Total volume traded: €6k. Activity tracked since 26 March 2025. The latest transaction was filed on 12 May 2026 (Attribution). Regulator: SEC (Form 4). The full history is openly available.
Declarations3 total
10,000 shares0Common StockSEC:0001193125-26-224140:0
10,000 shares0Common StockSEC:0001193125-26-224140
10,000 shares@ US$0.70100.0% of flowCommon StockSEC:0000950170-25-046742:0
Ideal exit: 21 Dec 2025 (T+270)
3 of 3 declarations
About Remmel H. Lawrence
Lawrence H. Remmel is a Director at ATOSSA THERAPEUTICS, INC. In this role, he contributes to the governance of the company and strategic decision-making. His experience in the biopharmaceutical sector is an asset to the board of directors. He plays a key role in the future direction of ATOSSA.
